Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use

Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use

US Patent 12214054 · Granted Feb 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genome engineering with CRISPR-Cas systems in eukaryotes2025
CRISPR/Cas9-based repressors for silencing gene targets in vivo and methods of u2025
Therapeutic applications of CPF1-based genome editing2025
Compositions and methods for the induction and tuning of gene expression2025
Compositions and methods for epigenome editing2025
Genetic correction of mutated genes2024
Genome engineering with Type I CRISPR systems in eukaryotic cells2024
Compositions and methods of improving specificity in genomic engineering using R2022
Genome engineering with type I CRISPR systems in eukaryotic cells2022
Compositions, systems and methods for cell therapy2022
Compositions and methods for epigenome editing2021
RNA-guided transcriptional regulation and methods of using the same for the trea2021